Rockefeller Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Rockefeller Capital Management's ARKG Position: Q3 2026 in Review
Rockefeller Capital Management increased its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q3 2026, buying an estimated $975K and bringing the position to 121,633 shares worth $6.59M. The position accounts for 0.01% of the portfolio, ranked #894.
Rockefeller Capital Management first reported a position in ARKG in Q3 2020 and has held it in 23 quarters since. The position peaked at $11.6M in Q3 2022. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Rockefeller Capital Management held 121,633 shares of ARK Genomic Revolution ETF worth $6.59M as of Q3 2026.
- Rockefeller Capital Management bought 21,675 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $975K.
- ARK Genomic Revolution ETF made up 0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #894 holding.
- Rockefeller Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 23 quarters since.
- Rockefeller Capital Management's ARK Genomic Revolution ETF position peaked at $11.6M in Q3 2022.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.